N-Hexacosanol

N/A

Report date: 2025/03/27 20:00:06
NME

Base Information

Drug NameN-Hexacosanol
Drug Alias NametCFA15TAC-302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor stimulants
TargetsNerve growth factor
Therapy Area/IndicationsUrinary Bladder, UnderactiveUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, UnderactiveUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A